WFL 0.00% 0.3¢ wellfully limited

Ann: Bodyguard Results, page-158

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,114 Posts.
    lightbulb Created with Sketch. 312
    What an interesting day. My question is if anyone came out of today with a resounding re-assurance? The results seemed to be very positive, however where exactly do we sit in the grand scheme of things? I'm a little confused

    This extract caught my eye in particular:

    "there is an opportunity for further product development and evaluation over a longer time frame but this is undoubtedly an important step forward"

    So the opportunity remains. The question is: Is it an opportunity or is it highly recommended that the product be further develop and evaluated but Professor Wright wanted to down play with 'opportunity'?

    Lets say P&G like the product and wish to distribute, do we then stick with the current product and commence commercialisation? Or is this product still to be developed before another clinical trial?
 
watchlist Created with Sketch. Add WFL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.